Healthcare

Browse All

Sumitomo Dainippon Pharma and Behavr Announce Landmark Deal for Multiple Virtual Reality <span class="dewidow">Digital Therapeutics</span>
In the News U.S. & Canada Healthcare

Sumitomo Dainippon Pharma and Behavr Announce Landmark Deal for Multiple Virtual Reality Digital Therapeutics

Development and commercialization plans include prescription digital therapeutics to treat social anxiety, generalized anxiety disorder, and major depressive disorder — with potential to impact millions worldwide.

CBS WABI 5